Bio


Dr. Sharon Abada is a fellowship-trained rheumatologist with Stanford Health Care. She is also a clinical assistant professor in the Department of Medicine, Division of Immunology & Rheumatology at Stanford University School of Medicine.

Dr. Abada diagnoses and treats a wide range of autoimmune and inflammatory diseases that affect connective tissues, such as gout and pseudogout, lupus, rheumatoid arthritis, and vasculitis. She also has experience treating rare conditions such as autoinflammatory syndromes and granulomatous mastitis.

Dr. Abada’s research focuses on improving care for vulnerable and underserved patient populations, including older adults and immunocompromised patients. She was awarded the Emerging Investigator Excellence Award by the American College of Rheumatology for her research on recombinant zoster vaccine prevalence among veterans receiving immunosuppression.

Dr. Abada has published her work in several peer-reviewed journals, including JAMA Network Open, Journal of Applied Gerontology, and Journal of General Internal Medicine. She has presented to her peers at national and regional meetings, including annual meetings of the American College of Rheumatology and the Society of General Internal Medicine.

Dr. Abada is a member of the American College of Rheumatology and the American Medical Association.

Clinical Focus


  • Rheumatology

Academic Appointments


Honors & Awards


  • Teaching Assistant of the Year, WashU School of Medicine
  • Roy R. Peterson Prize in Anatomy, WashU School of Medicine
  • Rheumatology Fellow of the Year Award, UCSF
  • Outstanding New Student Scholarship, UTHealth Houston School of Public Health
  • Nathan Hellman Memorial Award, WashU School of Medicine
  • Lawson Family Scholarship, WashU School of Medicine
  • Glasgow-Rubin Citation for Academic Achievement, American Medical Women’s Association
  • Excellence in Public Health Award, U.S. Public Health Service
  • Emerging Investigator Excellence Award, American College of Rheumatology
  • Dr. William A. Rubenstein Award in Medicine, WashU School of Medicine
  • Dr. Margaret G. Smith Award, WashU School of Medicine
  • Delta Omega Honorary Society in Public Health, UTHealth Houston School of Public Health
  • Dean’s Scholarship, UTHealth Houston School of Public Health
  • Class of 2003 Award, WashU School of Medicine
  • Book Prize, Alpha Omega Alpha Honor Society, WashU School of Medicine
  • Antoinette Frances Dames Award in Cell Biology and Physiology, Washington University (WashU) School of Medicine

Boards, Advisory Committees, Professional Organizations


  • Member, American Medical Association (2021 - Present)
  • Member, American College of Rheumatology (2023 - Present)

Professional Education


  • Board Certification: American Board of Internal Medicine, Internal Medicine (2024)
  • Fellowship: UCSF Rheumatology Fellowship (2026) CA
  • Residency: UCSF Dept of Internal Medicine (2024) CA
  • Medical Education: Washington University School Of Medicine (2021) MO

All Publications


  • Innate and Adaptive Immune Mechanisms in Pericarditis: Pathobiology and Clinical Implications. The Canadian journal of cardiology Zhang, C., Abada, S., Tasca, S., Moslehi, J. J., Baik, A. H. 2026; 42 (8): 1872-1888

    Abstract

    Pericarditis is an inflammatory disorder of the pericardium with a broad clinical spectrum, ranging from a single acute episode to recurrent, incessant, or chronic disease. Although most cases are idiopathic and self-limited, a subset of patients develop relapsing or treatment-resistant pericarditis marked by persistent inflammation, tissue remodelling, and, in severe cases, constrictive physiology. These clinical phenotypes support a model where pericarditis represents a spectrum of immune-mediated disease. In this review, we integrate clinical classification with emerging insights into innate and adaptive immunity to bridge pericarditis immunopathology with clinical presentation. Acute idiopathic pericarditis is commonly initiated by innate danger sensing through pattern-recognition receptors, triggering nuclear factor κB activation, NLRP3 inflammasome assembly, and interleukin (IL) 1α/1β driven inflammation. In recurrent disease, sustained activation of these pathways can establish self-amplifying inflammatory circuits involving IL-1, IL-6, tumor necrosis factor α, and JAK/STAT signalling, promoting leukocyte recruitment and fibroblast activation. Emerging clinical and serologic evidence further suggests that adaptive immune mechanisms contribute to disease persistence. These observations highlight that recurrent pericarditis exists along a continuum from predominantly autoinflammatory to mixed autoinflammatory and autoimmune disease. Insights from preclinical models, including viral, sterile inflammasome driven, cytokine-mediated, and autoimmune models, have validated these pathways and clarified mechanisms of pericarditis and its complications. This mechanistic understanding has strengthened the biological rationale underlying current therapeutic approaches. IL-1 inhibition has emerged as a paradigm-shifting treatment for recurrent pericarditis, whereas IL-6 blockade, JAK inhibition, and broader immunosuppression may benefit selected phenotypes. Future research should focus on defining immune endotypes, identifying predictive biomarkers, and aligning targeted therapies with the dominant inflammatory drivers.

    View details for DOI 10.1016/j.cjca.2026.04.017

    View details for PubMedID 42055116

  • Early Strawberry Gingivitis in Granulomatosis with Polyangiitis. Journal of general internal medicine Abada, S., Margaretten, M. E. 2026; 41 (7): 1996-1997

    View details for DOI 10.1007/s11606-026-10256-2

    View details for PubMedID 41688626

    View details for PubMedCentralID PMC13176398

  • Recombinant Zoster Vaccination Among US Veterans Receiving Immunosuppressive Medications. JAMA network open Abada, S., Li, J., Tarasovsky, G., Wilson, C., Yazdany, J., Whooley, M. A., Schmajuk, G. 2024; 7 (10): e2439945

    View details for DOI 10.1001/jamanetworkopen.2024.39945

    View details for PubMedID 39392634

    View details for PubMedCentralID PMC11581597

  • Student Response Initiatives: A Case Study of COVID-19 at Washington University MEDICAL SCIENCE EDUCATOR Chermside-Scabbo, C. J., Douglas, K., Ghaznavi, C., Pollard, B., Abada, S., Goodman, J., Migotsky, N., Park, K., Sherburne, H., Coolman, A., Aagaard, E. M., Lawrence, S. J. 2021; 31 (2): 365-369
  • Medication Regimen Complexity and Low Adherence in Older Community-Dwelling Adults With Substantiated Self-Neglect. Journal of applied gerontology : the official journal of the Southern Gerontological Society Abada, S., Clark, L. E., Sinha, A. K., Xia, R., Pace-Murphy, K., Flores, R. J., Burnett, J. 2017: 733464817714565

    Abstract

    Determine whether medication regimen complexity predicts medication adherence levels in a sample of community-dwelling adults 65 years and older with Adult Protective Services-substantiated self-neglect.A cross-sectional analysis of baseline data ( N = 31 participants) from a pilot intervention to increase medication adherence among the target group was performed. The Medication Regimen Complexity Index (MRCI) and the 8-item Morisky Medication Adherence Scale (MMAS-8)™ were the primary independent and dependent measures, respectively. A multivariable linear regression analysis, adjusting for potential confounders, was conducted to estimate the association between complexity and adherence.Regimen complexity was high (mean MRCI = 19.6) and adherence was low (mean MMAS = 5.1). Even after controlling for confounders, increased complexity was significantly associated with lower adherence.Older community-dwelling adults who self-neglect have complex medication regimens that contribute to low medication adherence. Medication regimen complexity may be a modifiable contributor to low adherence that can be targeted by future interventions to reduce self-neglect and its consequences.

    View details for DOI 10.1177/0733464817714565

    View details for PubMedID 28645225

  • Assessment of older adults' satisfaction with adult protective services investigation and assistance. Journal of elder abuse & neglect Booker, J. G., Breaux, M., Abada, S., Xia, R., Burnett, J. 2017; 30 (1): 64-74

    Abstract

    This study examined elder self-neglect client satisfaction with services provided by an Adult Protective Services (APS) program. A total of 77 community-dwelling older adults with APS-substantiated self-neglect responded to the standardized and widely used 8-item Client Satisfaction Questionnaire. Approximately 75% of the participants reported being satisfied with the overall services. They felt that the services provided were responsive to their need(s) and helped them deal with their problem(s). Greater than 80% responded that they would refer a friend, would utilize APS in the future if necessary, and were at least satisfied with the amount of help received. The extent to which their needs were met received the lowest satisfaction scores. Future studies are needed to examine elder self-neglect client satisfaction in relation to specific services.

    View details for DOI 10.1080/08946566.2017.1329045

    View details for PubMedID 28498035

  • Medication use and polypharmacy in older adults with substantiated self-neglect: A case study Self-Neglect in Older Adults: A Global, Evidence-Based Resource for Nurses and Other Healthcare Providers Burnett, J., Clark, L. E., Abada, S., Parker, K., Flores, R. J., Murphy, K. P. 2017
  • Stroke Knowledge in African Americans: A Narrative Review. Ethnicity & disease Sharrief, A. Z., Johnson, B., Abada, S., Urrutia, V. C. 2016; 26 (2): 255-62

    Abstract

    The purpose of this review is to evaluate the state of knowledge in regard to stroke literacy in African Americans. This topic is important for assessing the specific gaps in stroke knowledge for this population, as well as to evaluate the methodology that has been used to assess stroke literacy.This narrative review includes studies that evaluated and reported stroke knowledge in African Americans and were published between January 2000 and October 2015.Our review revealed that disparities may exist in recognition of headache and visual symptoms, knowledge of the organ in which stroke occurs, and identification of tobacco use as a risk factor. Stress may be perceived as a more important risk factor among African Americans than among White Americans. The literature does not suggest disparities in knowledge of the appropriate action to take for stroke.Racial disparities may exist for specific domains of stroke knowledge. Future studies should explore specific gaps in knowledge to be addressed in stroke prevention interventions for African Americans. Standardization of methods is needed to aid comparisons across populations. The relationship between stroke knowledge and clinical outcomes also needs to be evaluated.

    View details for DOI 10.18865/ed.26.2.255

    View details for PubMedID 27103777

    View details for PubMedCentralID PMC4836907